Wildy Logo
(020) 7242 5778
enquiries@wildy.com

Book of the Month

Cover of Company Directors: Duties, Liabilities and Remedies

Company Directors: Duties, Liabilities and Remedies

Edited by: Mark Arnold KC, Simon Mortimore KC
Price: £275.00

Lord Denning: Life, Law and Legacy



  


Welcome to Wildys

Watch


NEW EDITION Pre-order Mortgage Receivership: Law and Practice



 Stephanie Tozer, Cecily Crampin, Tricia Hemans
Practical guidance to relevant law & procedure


Offers for Newly Called Barristers & Students

Special Discounts for Newly Called & Students

Read More ...


Secondhand & Out of Print

Browse Secondhand Online

Read More...


Easter Closing

We will be closed between Friday 29th March and Monday 1st April for the Easter Bank Holidays, reopening at 8.30am on Tuesday 2nd April. Any orders received during this period will be processed with when we re-open.

Hide this message

Pharmaceutical Innovation, Competition And Patent Law


ISBN13: 9780857932457
Published: July 2013
Publisher: Edward Elgar Publishing Limited
Country of Publication: UK
Format: Hardback
Price: £126.00



Despatched in 3 to 5 days.

Public health, safety, and access to reasonably priced medicine are common policy goals of pharmaceutical regulations. As both the context for innovation and competitive structure change, industry actors dynamically challenge the balance between the incentive for protection and the achievement of those policy goals. Considering the arguments from the perspectives of innovation, competition law and patent law, this book explores the difficult question of balancing protection with access, highlighting the difficulties in harmonization and coordination.

The contributors to this book including academics, judges and practitioners from Europe, US and Japan, explore to what extent patent strategies and life-cycle management practices take advantage of patent laws and health-care regulation and disrupt the necessary balance between incentives for innovation and access to affordable medicine and health care. Addressing fundamental questions in the field of pharmaceutical innovation, this book will appeal to scholars and practitioners in intellectual property, competition law and life sciences regulation, as well as pharmaceutical companies and regulators.

Subjects:
Competition Law, Intellectual Property Law, Medical Law and Bioethics
Contents:
Introduction

PART I: PATENT PROTECTION FOR PHARMACEUTICAL METHODS
1. The Patentability of Genetic Diagnostics in U.S. Law and Policy
2. Patentability of Pharmaceutical Innovations - The European Perspective
3. Patentability of Medical Methods in Japan

PART II: DATA EXCLUSIVITY AND PATENT TERM EXTENSION - CONVERGENCE OR DIVERGENCE
4. Patent Term Restoration and Non-Patent Exclusivity in the United States
5. Clinical Data, Data Exclusivity and Private Investment Protection in Europe
6. Patent Term Extension in Japan - an Academic and Comparative Perspective
7. Recent United Kingdom Case Law On Supplementary Protection Certificates
8. Patent Term Extension in Japan - Focusing on the Pacif Capsule Decision
Apppendix Decision of Japanese Supreme Court, 28 April 2011

PART III: BALANCING INCENTIVES AND COMPETITION IN EUROPE
9. Strategic Patenting by Pharmaceutical Industry - Towards a Concept of Abusive Practices of Protection
10. Anticompetitive Marketing in the Context of Pharmaceutical Switching in Europe
11. AstraZeneca and the EU Sector Inquiry: When Do Patent Filings Violate Competition Law?

Index